GSK3 beta 抗体
(Glycogen Synthase Kinase 3 beta (GSK3b))
The protein encoded by this gene is a serine-threonine kinase, belonging to the glycogen synthase kinase subfamily. It is involved in energy metabolism, neuronal cell development, and body pattern formation. Polymorphisms in this gene have been implicated in modifying risk of Parkinson disease, and studies in mice show that overexpression of this gene may be relevant to the pathogenesis of Alzheimer disease. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| GSK3 beta 抗体 | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| GSK3 beta 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| GSK3 beta 抗体 (AA 362-395) | 大鼠 | 兔 Polyclonal |
|
|
|
| GSK3 beta 抗体 (AA 2-33) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| GSK3 beta 抗体 (pSer9) | 人 | 兔 Polyclonal |
|
|
|
| GSK3 beta 抗体 (AA 4-34) | 人 | 兔 Polyclonal |
|
|
|
| GSK3 beta 抗体 (AA 30-59) | 小鼠 | 兔 Polyclonal |
|
|
|
| GSK3 beta 抗体 | 人, 小鼠, 大鼠 | 小鼠 Monoclonal |
|
|
|
| GSK3 beta 抗体 (AA 122-375) | 大鼠 | 兔 Polyclonal |
|
|
|
| GSK3 beta 抗体 (N-Term) | 小鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2E6-D6-C12
- 标记
- unconjugated
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
1 reference - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB03816
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 4-34, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB56577
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 362-395
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB56641
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 2-33
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB56641
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 2-33, pSer9
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 4-34
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 30-59
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2E6-D6-C12
- 标记
- unconjugated
- 抗体亚型
- IgG2a
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 122-375
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 30-59, N-Term
Latest Publications for our GSK3 beta 抗体
: "Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway." in: Pharmacological research, Vol. 130, pp. 466-480, (2019) (PubMed).
: "Anti-neuroinflammatory effects of SLOH in Aβ-induced BV-2 microglial cells and 3xTg-AD mice involve the inhibition of GSK-3β." in: Neuroscience letters, Vol. 687, pp. 207-215, (2019) (PubMed).
: "Musashi 1-positive cells derived from mouse embryonic stem cells treated with LY294002 are prone to differentiate into intestinal epithelial-like tissues." in: International journal of molecular medicine, Vol. 43, Issue 6, pp. 2471-2480, (2019) (PubMed).
: "GSK-3 inhibition through GLP-1R allosteric activation mediates the neurogenesis promoting effect of P7C3 after cerebral ischemic/reperfusional injury in mice." in: Toxicology and applied pharmacology, Vol. 357, pp. 88-105, (2019) (PubMed).
: "Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patients." in: Brain, behavior, and immunity, Vol. 67, pp. 364-373, (2018) (PubMed).
: "ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway." in: Oncotarget, Vol. 7, Issue 40, pp. 65374-65388, (2018) (PubMed).
: "α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway." in: Oncogenesis, Vol. 6, Issue 5, pp. e343, (2018) (PubMed).
: "MicroRNA-200c impairs uterine receptivity formation by targeting FUT4 and α1,3-fucosylation." in: Cell death and differentiation, Vol. 24, Issue 12, pp. 2161-2172, (2018) (PubMed).
: "AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 32, Issue 7, pp. 3924-3935, (2018) (PubMed).
: "Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway." in: Marine drugs, Vol. 16, Issue 3, (2018) (PubMed).
: "Anti-neuroinflammatory effects of SLOH in Aβ-induced BV-2 microglial cells and 3xTg-AD mice involve the inhibition of GSK-3β." in: Neuroscience letters, Vol. 687, pp. 207-215, (2019) (PubMed).
: "Musashi 1-positive cells derived from mouse embryonic stem cells treated with LY294002 are prone to differentiate into intestinal epithelial-like tissues." in: International journal of molecular medicine, Vol. 43, Issue 6, pp. 2471-2480, (2019) (PubMed).
: "GSK-3 inhibition through GLP-1R allosteric activation mediates the neurogenesis promoting effect of P7C3 after cerebral ischemic/reperfusional injury in mice." in: Toxicology and applied pharmacology, Vol. 357, pp. 88-105, (2019) (PubMed).
: "Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patients." in: Brain, behavior, and immunity, Vol. 67, pp. 364-373, (2018) (PubMed).
: "ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway." in: Oncotarget, Vol. 7, Issue 40, pp. 65374-65388, (2018) (PubMed).
: "α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway." in: Oncogenesis, Vol. 6, Issue 5, pp. e343, (2018) (PubMed).
: "MicroRNA-200c impairs uterine receptivity formation by targeting FUT4 and α1,3-fucosylation." in: Cell death and differentiation, Vol. 24, Issue 12, pp. 2161-2172, (2018) (PubMed).
: "AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 32, Issue 7, pp. 3924-3935, (2018) (PubMed).
: "Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway." in: Marine drugs, Vol. 16, Issue 3, (2018) (PubMed).
Aliases for GSK3 beta 抗体
glycogen synthase kinase 3 beta (GSK3B) 抗体glycogen synthase kinase 3 beta (Gsk3b) 抗体
glycogen synthase kinase 3 beta (gsk3b) 抗体
glycogen synthase kinase 3 beta L homeolog (gsk3b.L) 抗体
7330414F15Rik 抗体
8430431H08Rik 抗体
C86142 抗体
fk80d11 抗体
GSK-3 抗体
gsk-3 抗体
GSK-3beta 抗体
GSK-3[b] 抗体
GSK3 抗体
gsk3 抗体
gsk3-beta 抗体
GSK3beta 抗体
gsk3beta 抗体
wu:fb68h05 抗体
wu:fk80d11 抗体
xgsk-3 抗体
您还需要查找其他产品吗？
You are here:
